S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.

EG Acquisition Stock Price, News & Analysis (NYSE:EGGF)

$10.68
-0.01 (-0.09%)
(As of 11/27/2023 ET)
Compare
Today's Range
$10.65
$11.54
50-Day Range
$10.52
$10.76
52-Week Range
$9.87
$12.11
Volume
21,935 shs
Average Volume
20,393 shs
Market Capitalization
$105.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

EGGF stock logo

About EG Acquisition Stock (NYSE:EGGF)

EG Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. EG Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

EGGF Stock Price History

EGGF Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
See More Headlines
Receive EGGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EG Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
11/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Air transportation, nonscheduled
Sub-Industry
N/A
Sector
Aerospace
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Net Income
$3.67 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.13 per share
Book Value
($0.47) per share

Miscellaneous

Free Float
7,886,000
Market Cap
$105.30 million
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report














EGGF Stock Analysis - Frequently Asked Questions

How have EGGF shares performed in 2023?

EG Acquisition's stock was trading at $9.97 at the beginning of the year. Since then, EGGF shares have increased by 7.1% and is now trading at $10.68.
View the best growth stocks for 2023 here
.

Are investors shorting EG Acquisition?

EG Acquisition saw a increase in short interest in October. As of October 31st, there was short interest totaling 300 shares, an increase of 50.0% from the October 15th total of 200 shares. Based on an average daily volume of 15,700 shares, the short-interest ratio is currently 0.0 days.
View EG Acquisition's Short Interest
.

Who are EG Acquisition's major shareholders?

EG Acquisition's stock is owned by a number of retail and institutional investors. Top institutional investors include Cowen AND Company LLC (0.57%) and Wolverine Asset Management LLC (0.55%).

How do I buy shares of EG Acquisition?

Shares of EGGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:EGGF) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -